Last reviewed · How we verify
NCT05005858: MRS
Modified Ridge Splitting Technique Using Autogenous Bone Blocks (MRS)
NA trial testing Alveolar ridge splitting in Alveolar Bone Resorption in 40 participants. Status unknown.
1 August 2020
Quick facts
| Lead sponsor | Semmelweis University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 14 May 2019 |
| Primary completion | 1 August 2020 |
| Estimated completion | 1 January 2023 |
| Sites | 1 location across Hungary |
Drugs / interventions tested
- Alveolar ridge splitting
- Creating osteotomies with piezoelectric device
Conditions studied
- Alveolar Bone Resorption — all drugs for Alveolar Bone Resorption →
- Alveolar Ridge Enlargement — all drugs for Alveolar Ridge Enlargement →
Sponsor
Semmelweis University
Who can join
18 and older, any sex, with Alveolar Bone Resorption or Alveolar Ridge Enlargement. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this clinical study ridge splitting procedures are preformed using autogenous bone blocks. After a 3-month healing, at the time of dental implant placement bone core biopsy samples are harvested. The samples undergo micro-Ct and histomorphometric analysis.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Microarchitectural Study of the Augmented Bone Following a Modified Ridge Splitting Technique: Histological and Micro-Computed Tomography Analyses.
Pénzes D, Szerencse C, Major M, Szabó G, et al · · 2024 · PMID 39597823 · DOI 10.3390/jcm13226679
Verify or expand the search:
- PubMed search for NCT05005858
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Alveolar Bone Resorption
Currently open trials in the same condition.
- NCT07404098 — Efficacy Of Eggshell-Derived Nanohydroxyapatite Based Mineralized Plasmatic Matrix Versus Xenogeneic Based Mineralized P · NA · active not recruiting
- NCT05937035 — Histological and Volumetric Evaluation of Customized Allograft Bone Blocks · NA · recruiting
- NCT07028606 — Vertical Ridge Augmentation Using Computer-guided Sandwich Osteotomy Technique · Phase 1 · active not recruiting
- NCT05577663 — Guided Bone Regeneration in Alveolar Socket · NA · recruiting
Other Semmelweis University trials
Trials by the same sponsor.
- NCT07519382 — Comparing the Clinical Success of Two Different CAD/CAM Full Cuspal Coverage Onlays · NA · enrolling by invitation
- NCT07474662 — Comparing the Effectiveness of Online vs. Face-to-face Physiotherapy for Treating Temporomandibular Disorders · NA · recruiting
- NCT07392853 — Investigation of the Effectiveness of Prophylactic NPWT (ciNPWT) in High-risk Diabetic Patients With Acute Laparotomy Wo · NA · not yet recruiting
- NCT07238296 — Prophylactic Sphincterotomy in Acute Biliary Pancreatitis Patients Unfit for Surgery · NA · not yet recruiting
- NCT07104370 — Freeze-dried Bone Allograft vs Autologous Bone Blocks in the Lateral Augmentation of the Jaws · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05005858 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Semmelweis University
- Last refreshed: 16 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05005858.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing